Skip to main content
. 2017 Oct 6;11:555. doi: 10.3389/fnins.2017.00555

Table 10.

Limitations and opportunities.

TYPE Barriers/limitations Challenges and opportunities
Experimental Dataset High number of subjects must be recruited to validate the results of the studies.
Dataset Patients with mild impairments (HY = 1) should be investigated to promote early diagnosis.
Dataset Age-matched controls should be involved, because motor performance vary with age.
Technological Acceptability The system should be developed with consideration for patients' requirements and needs.
Usability The system should be easy to use and eventually provide user-friendly interfaces both for clinician and patients.
Portability and unobtrusiveness The system should be wireless and non-invasive for use at home or outdoors without limitations for the patients. The number of sensors used and their placement over the body should address the trade-off between accuracy in measurements and obtrusiveness.
Long-term monitoring The system should ensure long-term operation. Long-term battery and low-power solutions have to be adopted, especially for home-monitoring applications for advanced patients with motor fluctuations.
Measurements The system should provide quantitative, accurate, precise, objective, and reliable measurements of the symptoms analyzed to actively support the clinician in diagnosis and management of the pathology.
The system should be able to recognize different stages of the disease as well as to evaluate changes due to pharmacological treatments.
Clinical Availability for use in clinical practice - Accuracy, precision, reliability, and dependability of the system should be ensured.
- Objective support for clinical examination and assessment should be validated, complying with traditional medical scales.
- Improvements for patients' management should be efficiently demonstrated.